PMVP: PMV Pharmaceuticals, Inc. - Summary | Jitta

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

Price
$1.09
Loss Chance
58.9%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (7)
Recent Business Performance (17)
Financial Strength (21)
Return to Shareholders (0)
Competitive Advantage (5)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent Business PerformanceEarning decline 61.83% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
2.21
131.87%
3.05
163.37%
Biotechnology
5.68
37.57%
5.68
37.57%
6.36
42.65%
COMPANY DESCRIPTION
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.